Pharmacoeconomic evaluation of using enzalutamide for treatment of patients with metastatic hormone-sensitive prostate cancer

N. A. Avxentyev; E. V. Derkach; Yu. V. Makarova

Cancer Urology
Onkourologiâ

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

User

eng | рус

Cancer Urology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Avxentyev N.A., Derkach E.V., Makarova Yu.V. Pharmacoeconomic evaluation of using enzalutamide for treatment of patients with metastatic hormone-sensitive prostate cancer. Cancer Urology. 2022;18(1):90-105. (In Russ.) https://doi.org/10.17650/1726-9776-2022-18-1-90-105

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Boris Ya. Alekseev

About the Authors

N. A. Avxentyev
Financial Research Institute, Ministry of Finance of Russia; Russian Presidential Academy of National Economy and Public Administration
Russian Federation

Nikolay A. Avxentyev

Build 2, 3 Nastas’inskiy Pereulok, Moscow 127006,

82 Vernadskogo Prospekt, Moscow 119571

E. V. Derkach
Russian Presidential Academy of National Economy and Public Administration; National Center for Health Technology Assessment
Russian Federation

82 Vernadskogo Prospekt, Moscow 119571,

12 Butlerova St., Moscow 117485

Yu. V. Makarova
Financial Research Institute, Ministry of Finance of Russia
Russian Federation

Build 2, 3 Nastas’inskiy Pereulok, Moscow 127006

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cancer Urology

For citations:

Cookies policy